Operations & Approach
At EmVenio, our approach is grounded in reach, reliability, and relationships—making clinical trials more accessible, inclusive, and impactful.
Our Approach
We bring clinical research to patients—wherever they are—through mobile and virtual visits, community-based sites, and hospital-based research centers. By bridging physical, cultural, and systemic gaps, we expand access and remove barriers to participation.
Our operations are defined by quality, safety, precision, efficiency, and empathy. We adapt quickly while maintaining scientific integrity, valuing every protocol and data point. We communicate clearly and compassionately, understanding both the hopes of patients and the goals of researchers. This human-centered approach drives long-term engagement and industry-leading retention.
Benefits
Improved Recruitment & Faster Enrollment
Mobile, virtual, and community-based options make participation easier and more convenient, accelerating study enrollment
Greater Retention & Lower Dropout Rates
Flexible options and reduced travel burdens support continued participation
Personalized engagement and regular follow-ups from local clinicians
Reliable Data & Protocol Adherence
Experienced staff implement every protocol with precision, ensuring scientific integrity
Oversight supports consistent, high-quality data collection
Reaching Underrepresented Populations
Home and community-based research removes geographic and systemic barriers
Locally embedded researchers build trust within diverse communities
Data Quality
Our data quality framework ensures compliance with GCP and GDPR, protecting patient rights and maintaining ethical standards.
Rigorous quality assurance, mobile clinician oversight, and real-time audit readiness ensure data is consistently accurate, verifiable, and accessible throughout every study.
Processes and technology are designed to meet Good Clinical Practice (GCP) and GDPR requirements—safeguarding patient rights and ensuring legal, ethical, and secure data handling throughout every study.
Ongoing, standardized quality control checks, staff training, and system validations minimize protocol deviations and ensure data is accurate, complete, and verifiable.
Thorough documentation and real-time digital source data enables immediate access, supporting prompt, transparent sponsor/ regulatory audits at any stage of a study.
Trained clinicians ensure every data point is collected accurately and consistently in any setting.
Clinical Operations
Our clinical operations approach ensures seamless, compliant execution across all visit types through centralized scheduling, real-time data capture, and integrated team communication.
Digital platforms and dedicated teams enable immediate oversight, transparent coordination, and staffing—supporting protocol adherence and patient-centric delivery at scale.
Centralized systems and dedicated teams manage every patient visit—whether site-based or remote—with precision and consistency. Integrated scheduling, automated reminders, and seamless consent tracking ensure smooth execution and high compliance.
Digital eSource platforms and centralized monitoring enable immediate, secure data collection and reconciliation. Real-time alerts and deviation tracking support rapid decision-making and maintain protocol fidelity.
Connected digital tools give all clinical teams—onsite and remote—transparent access to study updates, visit schedules, and patient data. This ensures alignment, reduces errors, and supports continuous quality control.
Our operational approach supports a range of delivery options—including site-based, community, mobile, and virtual visits—allowing sponsors to tailor study
“EmVenio is a pleasure to work with. Staff is knowledgeable and reports are completed promptly keeping patient records up to date. Emails are answered promptly and with accuracy.”
— Site Coordinator
Therapeutic Expertise
Therapeutic Areas of Expertise
Therapeutic Indications
Clinical Trial Study Experience
Clinician of the Month
Michelle Mallitz, MD, is a board-certified internal medicine physician and Lead Principal Investigator at EmVenio with 30 years of clinical experience and 13 years in clinical research. She brings deep expertise across a broad range of therapeutic areas, with work spanning over 120 clinical trials, including extensive involvement in cardiometabolic research.
Michelle Mallitz, M.D.
Principal Investigator
Trial Phases We Cover
EmVenio supports all clinical trial phases—from Phase 1 safety and dosing studies through Phase 4 post-marketing research. Every study is unique, so our approach consisting of home visits, virtual visits, community and traditional sites, adapts to each study’s operational and compliance needs, maximizing patient access and ensuring high-quality data for sponsors.
Global Reach
With capabilities in over 90+ countries, we can reach more patients while keeping them engaged and retained in your study.
Key Statistics
Countries
Overcoming geographical barriers with a presence in 100+ countries—bringing research to where people live.
Sponsors
Trusted by 200+ sponsors who rely on our precision, efficiency, and commitment to quality.
Studies
Delivering results across 800+ clinical studies—powered by community insight and scientific rigor.
Visits
100,000+ patient visits made possible through empathy, access, and industry-leading retention.